Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/24715266/ below:

Variation in medicaid coverage for hematopoietic cell transplantation

Affiliations

• ¹ National Marrow Donor Program; and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
• ² National Marrow Donor Program; and Center for International Blood and Marrow Transplant Research, Minneapolis, MN nmajhail@nmdp.org.

• PMID: 24715266
• PMCID: PMC4135085
• DOI: 10.1200/JOP.2013.001155

Item in Clipboard

Jaime M Preussler et al. J Oncol Pract. 2014 Jul.

• ¹ National Marrow Donor Program; and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
• ² National Marrow Donor Program; and Center for International Blood and Marrow Transplant Research, Minneapolis, MN nmajhail@nmdp.org.

• PMID: 24715266
• PMCID: PMC4135085
• DOI: 10.1200/JOP.2013.001155

Item in Clipboard

Purpose: Variation in Medicaid policies among states may lead to differences in coverage for complex treatments. This article uses hematopoietic cell transplantation (HCT), an established treatment for patients with hematologic cancers, as a case study to highlight state variation in Medicaid coverage of complex oncology treatments.

Methods: Information on HCT coverage benefits for 2012 was collected from state Medicaid Web sites and was compared with recommended HCT benefits developed by multiple stakeholders. Coverage was reviewed for five categories: one, transplantation procedure; two, donor search; three, prescriptions; four, clinical trials; and five, patient food, lodging, and transportation. Coverage was coded on a three-point scale for each category for each state. States were ranked by the number of variables for which they met recommended benefits criteria (maximum rank score, 5).

Results: Detailed information on Medicaid coverage was available for 47 states. No state provided the recommended coverage benefits in all five categories. Prescription coverage most often met the recommended criteria, whereas only a small number of states provided clinical trial coverage for HCT. There was substantial variation in Medicaid coverage for HCT by state.

Conclusion: Findings highlight substantial variation in Medicaid coverage for HCT by state, which may increase disparities in access for already medically underserved populations.

Copyright © 2014 by American Society of Clinical Oncology.

PubMed Disclaimer

Medicaid coverage for hematopoietic cell…

Medicaid coverage for hematopoietic cell transplantation by state. Each state was coded on…

Medicaid coverage for hematopoietic cell transplantation by state. Each state was coded on whether it provided recommended benefits for transplantation on a three-point scale (coverage met criteria, score of 2; met some but not all criteria, score of 1; or did not meet any criteria, score of 0) for the following five categories: (1) transplantation procedure and disease indications; (2) donor search; (3) medications; (4) clinical trials; and (5) patient food, lodging, and transportation. States were ranked by the number of categories for which they met recommended benefits criteria (maximum score, 5).

• Surveillance for Health Care Access and Health Services Use, Adults Aged 18-64 Years - Behavioral Risk Factor Surveillance System, United States, 2014.

  Okoro CA, Zhao G, Fox JB, Eke PI, Greenlund KJ, Town M. Okoro CA, et al. MMWR Surveill Summ. 2017 Feb 24;66(7):1-42. doi: 10.15585/mmwr.ss6607a1. MMWR Surveill Summ. 2017. PMID: 28231239 Free PMC article.

• A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD).

  Mupfudze TG, Preussler JM, Sees JA, SanCartier M, Arnold SD, Devine S. Mupfudze TG, et al. Transplant Cell Ther. 2021 Apr;27(4):345-351. doi: 10.1016/j.jtct.2021.01.022. Epub 2021 Jan 29. Transplant Cell Ther. 2021. PMID: 33836889

• Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative.

  Auletta JJ, Khera N, DeMartino P, Kelkar AH, Yusuf RA, Davies SM, Knutson J, Beaver E, Maloney A, Majhail NS. Auletta JJ, et al. Transplant Cell Ther. 2023 Nov;29(11):713-720. doi: 10.1016/j.jtct.2023.08.007. Epub 2023 Aug 12. Transplant Cell Ther. 2023. PMID: 37579920

• Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?

  Malik AT, Alexander J, Khan SN, Scharschmidt TJ. Malik AT, et al. Clin Orthop Relat Res. 2021 Mar 1;479(3):493-502. doi: 10.1097/CORR.0000000000001438. Clin Orthop Relat Res. 2021. PMID: 32805094 Free PMC article.

• Improving health insurance coverage for Latino children: a review of barriers, challenges and State strategies.

  Zambrana RE, Carter-Pokras O. Zambrana RE, et al. J Natl Med Assoc. 2004 Apr;96(4):508-23. J Natl Med Assoc. 2004. PMID: 15101671 Free PMC article. Review.

• Estimating demand and unmet need for allogeneic hematopoietic cell transplantation in the United States using geographic information systems.

  Besse KL, Preussler JM, Murphy EA, Denzen EM, Lill MC, Chell JW, Senneka MK, Majhail NS, Williams EP. Besse KL, et al. J Oncol Pract. 2015 Mar;11(2):e120-30. doi: 10.1200/JOP.2014.000794. J Oncol Pract. 2015. PMID: 25784576 Free PMC article.

• Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers.

  Preussler JM, Mau LW, Majhail NS, Bevans M, Clancy E, Messner C, Parran L, Pederson KA, Ferguson SS, Walters K, Murphy EA, Denzen EM. Preussler JM, et al. Support Care Cancer. 2016 Mar;24(3):1167-74. doi: 10.1007/s00520-015-2872-9. Epub 2015 Aug 15. Support Care Cancer. 2016. PMID: 26275767 Free PMC article.

• Persistent Disparities in Adult Hematopoietic Cell Transplantation.

  Crockett DG, Loberiza FR Jr. Crockett DG, et al. Curr Hematol Malig Rep. 2015 Sep;10(3):192-8. doi: 10.1007/s11899-015-0268-z. Curr Hematol Malig Rep. 2015. PMID: 26104908 Review.

• Overview of nutritional approach in hematopoietic stem cell transplantation: COVID-19 update.

  Akbulut G, Yesildemir O. Akbulut G, et al. World J Stem Cells. 2021 Oct 26;13(10):1530-1548. doi: 10.4252/wjsc.v13.i10.1530. World J Stem Cells. 2021. PMID: 34786156 Free PMC article. Review.

• Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings.

  Unger JM, Blanke CD, LeBlanc M, Barlow WE, Vaidya R, Ramsey SD, Hershman DL. Unger JM, et al. JAMA Netw Open. 2020 Apr 1;3(4):e203842. doi: 10.1001/jamanetworkopen.2020.3842. JAMA Netw Open. 2020. PMID: 32352530 Free PMC article.

1. 1. Medicaid and CHIP Payment and Access Commission. Report to the Congress on Medicaid and CHIP. https://docs.google.com/viewer?a=v&pid=sites&srcid=bWFjcGFjLmdvdnxtYWNwY....
2. 1. Reference deleted.
3. 1. Reference deleted.
4. 1. Pasquini MC, Wang Z, Horowitz MM, et al. 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): Current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl. 2010;2010:87–105. - PubMed
5. 1. Gratwohl A, Baldomero H, Aljurf M, et al. Hematopoietic stem cell transplantation: A global perspective. JAMA. 2010;303:1617–1624. - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3